Literature DB >> 58149

Cancer of the uterine corpus after hormonal treatment for breast cancer.

R Hoover, J F Fraumeni, R Everson, M H Myers.   

Abstract

Among 45853 women in whom breast cancer was diagnosed after age forty-nine, from the series of the End Results Program of the National Cancer Institute, cancer of the uterine corpus subsequently developed in 203. The risk was greater among those women receiving hormones than in other treatment groups, and tended to rise with increasing interval from first treatment. One method of estimating an expected value indicated that the excess risk of corpus cancer in breast-cancer patients was restricted to those treated with hormones. Given the time period under study, it may be assumed that the hormones were primarily non-steroidal oestrogens.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58149     DOI: 10.1016/s0140-6736(76)92099-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Suppression of Estrogenic Activity by Medroxyprogesterone Acetate in Tamoxifen-treated Patients after Surgery for Breast Cancer to Reduce the Risk of Endometrial Cancer Development.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

Review 2.  Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects.

Authors:  Casey E Reed; Suzanne E Fenton
Journal:  Birth Defects Res C Embryo Today       Date:  2013-06

3.  Mortality in women given diethylstilbestrol during pregnancy.

Authors:  L Titus-Ernstoff; R Troisi; E E Hatch; J R Palmer; L A Wise; W Ricker; M Hyer; R Kaufman; K Noller; W Strohsnitter; A L Herbst; P Hartge; R N Hoover
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

4.  Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy.

Authors:  L Titus-Ernstoff; E E Hatch; R N Hoover; J Palmer; E R Greenberg; W Ricker; R Kaufman; K Noller; A L Herbst; T Colton; P Hartge
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

5.  Environmental Factors Involved in Maternal Morbidity and Mortality.

Authors:  Abee L Boyles; Brandiese E Beverly; Suzanne E Fenton; Chandra L Jackson; Anne Marie Z Jukic; Vicki L Sutherland; Donna D Baird; Gwen W Collman; Darlene Dixon; Kelly K Ferguson; Janet E Hall; Elizabeth M Martin; Thaddeus T Schug; Alexandra J White; Kelly J Chandler
Journal:  J Womens Health (Larchmt)       Date:  2020-11-18       Impact factor: 2.681

6.  Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection.

Authors:  Stephen Wilson; Juliet Greenslade; Gillian Saunders; Catherine Holcroft; Lynn Bruce; Andy Scobey; Tedd Childers; Gordon Sture; James Thompson
Journal:  BMC Vet Res       Date:  2012-07-28       Impact factor: 2.741

7.  Endometrial cancer following treatment for breast cancer: a case-control study in Denmark.

Authors:  M Ewertz; S G Machado; J D Boice; O M Jensen
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

8.  Multiple primary cancers in Connecticut, 1935-82.

Authors:  J D Boice; R E Curtis; R A Kleinerman; J T Flannery; J F Fraumeni
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct

9.  Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study.

Authors:  A Paganini-Hill; R K Ross; B E Henderson
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

10.  Methodologic perspectives on the study of multiple primary cancers.

Authors:  W D Thompson
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.